Keywords: CHD; coronary heart disease; COX-2; cyclooxygenase-2; DIO; diet-induced obesity; GFR; glomerular filter rate; HMG Co-A; hydroxymethyl glutaryl-CoA; HCC; hepatocellular carcinoma; IL-1β; interleukin-1 β; iNOS; inducible nitic oxide synthase; LDL-C; low d
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Familial hypercholesterolemia; Statins; LDL-C; Goal levels;
Keywords: PCOS; polycystic ovary syndrome; BMI; mody mass index; HDL-C; high density lipoprotein-C; LDL-C; low density lipoprotein-C; CVD; cardiovascular disease; FSH; follicle stimulating hormone; LH; luteinizing hormone; T2DM; type 2 diabetes mellitus; GPO-PAP; g
Keywords: PCSK9 inhibitor; Alirocumab; Expanded use; Heterozygous familial hypercholesterolemia; Coronary heart disease; LDL-C; Statin intolerance; ODYSSEY;
Keywords: AIMS; the Abnormal Involuntary Movement Scale; BARS; the Barnes Akathisia Rating Scale; BMI; body mass index; GSH; glutathione; HDL-C; high-density lipoprotein-cholesterol; LDL-C; low-density lipoprotein-cholesterol; NAC; N-acetyl-l-cysteine; MINI; Mini I
Keywords: ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BMI; body mass index; HOMA-IR; homeostatic model assessment insulin resistance; GGT; Gamma glutamyl transpeptidase; HDL-C; high density lipoprotein cholesterol; INR
Keywords: Asthma; Healthy subjects; Obesity; Periostin; Rhinitis; ALT; alanine aminotransferase; AR; allergic rhinitis; AST; aspartate aminotransferase; BMI; Body mass index; BUN; blood urea nitrogen; Cre; creatinine; eGFR; estimate glomerular filtration rate; FEV1
Keywords: Discontinuation; Lipid-lowering drug; Pharmacoepidemiology; Medication; Measurement; Cardiovascular disease; Primary prevention; Interrupción; Fármaco hipolipemiante; FarmacoepidemiologÃa; Medicación; Medición; Enfermedad cardiovascular; Prevención
Keywords: Uric acid; Hyperuricemia; Acute coronary syndrome; Percutaneous coronary intervention; Long-term adverse outcomes; ACE-I; angiotensin-converting-enzyme inhibitor; ACS; acute coronary syndrome; ARB; angiotensin-receptor blocker; ASS; acetylsalicylic acid;
Keywords: Green tea; Epigallocatechin gallate; Colon polyps; Recurrence risk; ALT; alanine transaminase; AST; aspartate transaminase; BMI; body mass index; CI; confidence interval; CRC; colorectal cancer; EGCG; (â)-epigallocatechin gallate; GTE; green tea extract
Keywords: Diabetes; Insulin resistance; Dyslipidemia; TG to HDL-C ratio; BMI; body-mass index; WC; waist circumference; FPG; fasting plasma glucose; HbA1c; Hemoglobin A1c; TG; triglycerides; TC; total cholesterol; HDL-C; high-density lipoprotein cholesterol; LDL-C;
Keywords: CDS; Chinese Diabetes Society; HbA1c; haemoglobin A1c; LDL-C; low-density lipoprotein cholesterol; FPG; fasting plasma glucose; HDL-C; high-density lipoprotein cholesterol; SCr; serum creatinine levels; eGFR; estimated glomerular filtration rate; RCTs; ra
Keywords: BMI; body mass index; FBG; fasting blood glucose; HDL-c; high-density lipoprotein cholesterol; LDL-c; low-density lipoprotein cholesterol; TG; triglyceride; TB; total bilirubin; ALT; alanine aminotransferase; TP; total protein; ALB; Albumin; BUN; urea nit
Keywords: ACCORD; Action to Control Cardiovascular Risk in Diabetes; aDCSI; adapted Diabetes Complication Severity Index; AGE; advanced glycation end product; Apo; apolipoprotein; BRB; blood-retina barrier; CI; confidence interval; DDD; defined daily dose; DM; di
Keywords: BMI; body mass index; CI; confidence interval; CVD; cardiovascular diseases; HDL-C; high-density lipoprotein cholesterol; LDL-C; low-density lipoprotein cholesterol; NO2; nitrogen dioxide; OR; odds ratio; O3; ozone; PM1; particles with diameters â¤1.0â¯
Keywords: NIC; nicotine; JAK2; janus tyrosine kinase; STAT3; signal transducer and activator of transcription 3; SOCS3; suppressor of cytokine signaling 3; OB-R; leptin receptors; GD; gestational day; isSWAT; interscapular subcutaneous white adipose tissue; igSWAT;
Keywords: Theobromine; Postprandial; Lipid metabolism; Glucose metabolism; Microarray; apoA-I; apolipoprotein A-I; apoB100; apolipoprotein B100; apoB48; apolipoprotein B48; CVD; cardiovascular diseases; CYP1A2; cytochrome P450 1A2; CYP2E1; cytochrome P450 2E1; dAUC
Keywords: ATTD; apparent total tract digestibility; CF; crude fiber; CP; crude protein; CRL; crown-rump length; DF; dietary fiber; DM; dry matter; DT; digestive tract; EE; ether extract; FFA; free fatty acid; GTT; glucose tolerance test; HDL-C; high-density lipopro
Keywords: BMI; body mass index; CI; confidence intervals; CK; creatine kinase; LDL-C; low-density lipoprotein cholesterol; PRISMA; Preferred Reporting Items for Systematic Reviews and Meta-Analyses; PROSPERO; International Prospective Register for Systematic Review
Keywords: AF; atrial fibrillation; AHA; American Heart Association; AHRQ; Agency of Healthcare Research and Quality; ALA; alpha-linolenic acid; ASA; aspirin; BP; blood pressure; CHD; coronary heart disease; CKD; chronic kidney disease; CV; cardiovascular; CVD; card
Keywords: Breastfeeding; LDL-C; Non-HDL-C; Triglyceride; Long-term breastfeeding;
Keywords: BMI; body mass index; CDW; Carolina Data Warehouse for Health; EMS; emergency medical services; HDL-C; high-density lipoprotein cholesterol; LDL-C; low-density lipoprotein cholesterol; NHANES; National Health and Nutrition Examination Survey; OHSUD; out-o
Keywords: PTP1B; protein tyrosine phosphatase 1B; CNS; central nervous system; HFD; high fat diet; NPY; neuropeptide Y; AMPK; 5' AMP-activated protein kinase; BAT; brown adipose tissue; AF; albiflorin; hAMSCs; human adipose tissue-derived mesenchymal stem cells; PP
Keywords: ACAT; acyl-coenzyme A:cholesterol acyltransferases; BSH; bile salt hydrolase; CFU; colony-forming unit; FAS; fatty acid synthase; FXR; farnesoid X receptor; GA; gum Arabic; GLP; glucagon-like peptides; HDL-C; high density lipoproteins cholesterol; HFD; hi
Keywords: CSFA; calcium salt of long-chain fatty acid; CP; crude protein; VFA; volatile fatty acid; DM; dry matter; OM; organic matter; EE; ether extract; NDF; neutral detergent fiber; ADF; acid detergent fiber; NH3-N; ammonia nitrogen; LDL-C; low-density lipoprote
Keywords: coronary; dyslipidemia; failure; fibrillation; insurance; sudden death; AF; atrial fibrillation; ASCVD; atherosclerotic cardiovascular disease; BP; blood pressure; CPVT; catecholaminergic polymorphic ventricular tachycardia; D2B; door-to-balloon; HFpEF; h
Keywords: ASCVD; atherosclerotic cardiovascular disease; BMI; body mass index; BP; blood pressure; CHD; coronary heart disease; CHF; congestive heart failure; DM; diabetes mellitus; FH; family history of coronary heart disease; FRA; Familial Risk Assessment; FRS; F
Keywords: adolescent; type 2 diabetes mellitus; lipids; insulin; inflammatory markers; apoB; Apolipoprotein B; BMI; Body mass index; HbA1c; Glycated hemoglobin A1c; HDL-C; High-density lipoprotein cholesterol; hs-CRP; High-sensitivity C-reactive protein; IL-6; Inte
Keywords: Citrus polymethoxyflavones; Metabolic disorder regulation; Anti-inflammation; Neuro-protection; Anti-cancer; ACC; acetyl-coA carboxylase; Akt; protein kinase B; AMPK; AMP-activated protein kinase; BaP; benzo[a]pyrene; C/EBP; CCAAT/enhancer-binding protein
Keywords: Bamboo-shaving polysaccharide (BSP); Prebiotic; Gut microbiota; Inflammation; Obesity; Insulin resistance; BSP; bamboo-shaving polysaccharide; IL; interleukin; TNF-α; tumor necrosis factor alpha; MCP-1; monocyte chemoattractant protein-1; LPS; lipopolysa
Keywords: 2hPPPG; post-prandial plasma glucose; ANOVA; analysis of variance; AUC; area under the curve; CKD; chronic kidney disease; Creat; serum creatinine; DBP; diastolic Blood Pressure; DN; diabetic nephropathy; DM; diabetes mellitus; eGFR; estimated glomerular
Keywords: diet; fatty acids; metabolomics; metabolic profiling; primordial prevention; BMI; Body mass index; E%; Percentage of total energy intake; HDL; High-density lipoprotein; HDL-C; High-density lipoprotein cholesterol; IDL; Intermediate-density lipoprotein; LD
Keywords: alirocumab; chronic kidney disease; impaired renal function; LDL-C; PCSK9; safety;
Keywords: Sex differences; Steroids; Gut microbiota; Metabolic disease; Cardiovascular disease; ApoE; apolipoprotein E; BAs; bile acids; CVD; cardiovascular diseases; E1; estrone; E2; estradiol; E3; estriol; ER; estrogen receptor; FCG; four core genotypes; FMO3; fl
Keywords: HMG-CoA; 3-hydroxy-3-methyl glutaryl-coenzyme A; BUN; Blood urea-nitrogen; BMI; Body mass index; BCAAs; Branched-chain amino acids; CMD; Cardiometabolic disorders; CD; Cardiovascular disease; CKD; Chronic kidney diseases; CRP; C reactive protein; DMA; Dim
Keywords: T2DM; type 2 diabetes; T1DM; type 1 diabetes; GPMSSP; General Practitioners' Morbidity Sentinel Stations Program; OR; odds ratio; 95%CI; 95% confidence interval; EUBIROD; EUropean Best Information through Regional Outcomes in Diabetes; NIHIFM; National
Keywords: ALT; alanine aminotransferase; BMI; body mass index; CDC; Centers for Disease Control and Prevention; CI; confidence interval; EtFOSAA; 2-(N-ethyl-perfluorooctane sulfonamido) acetate; GAM; generalized additive models; GFR; glomerular filtration rate; HDL
Keywords: coagulation; diabetes; lipoprotein; lung injury; TB; AFB; acid-fast bacillus; aOR1; OR after being adjusted for sex, age, and BMI; aOR2; OR after being adjusted for sex, age, BMI, and no DM/DM status; ApoA; apolipoprotein A; DM; diabetes mellitus; DM-TB;
Keywords: ASCVD; atherosclerotic cardiovascular disease; BMI; body mass index; BP; blood pressure; BaPTEQ; toxic equivalent concentration of benzo[a]pyrene; CI; confidence interval; CVD; cardiovascular diseases; DI; daily intakes; DBP; diastolic blood pressure; FPG
Keywords: Nitroalkene; Nitro-fatty acid; Electrophiles; Clinical trial; Preclinical development; Bardoxolone-me; Dimethyl fumarate; Nrf2; Nf-kB; Fibrosis; Inflammation; NO2-OA; nitro-oleic acid; NO2-FA; nitro-fatty acid; CXA-10; 10-nitro-oleic acid (10-nitro-octade
Keywords: apolipoproteins; cholesterol; low-density lipoproteins; population; risk; total burden; apo B; apolipoprotein B; FH; familial hypercholesterolemia; LDL; low-density lipoprotein; LDL-C; low-density lipoprotein cholesterol; NNT; number needed to treat;
Keywords: aPTT; activated partial thrombosplatin time; BMI; body mass index; FMD; flow-mediated dilation; HDL-c; high density lipoprotein cholesterol; LDL-c; low-density lipoprotein cholesterol; MMP-9; matrix metalloproteinase-9; OSI; oscillatory shear index; OSS;
Keywords: CSHT; cross-sex hormone therapy; FtM; female to male; HDL-c; high density lipoprotein cholesterol; LDL-c; low density lipoprotein cholesterol; MtF; male to female; SHBG; sex hormone binding globulin; ɣ-GT; ɣ-glutamyl transferase; Gender identity dysphor
Keywords: CKD; Chronic kidney disease; TG; Triglyceride; AOR; Adjusted odds ratio; COR; Crude odds ratio; MDRD-4; Modification of diet in renal disease 4 variables; HbA1c; Glycated haemoglobin; LDL-C; Low density lipoprotein cholesterol; WHO; World Health Organizat
Keywords: cardiovascular diseases; combination therapy; ezetimibe; LDL-C; rosuvastatin;
Keywords: AJ; adherent junction; ApoA1; apoprotein-A1; Apo-B; apoprotein-B; BBB; blood-brain barrier; Chol; Cholesterol; CI; confidence interval; DM; diabetes mellitus; DWM; deep white matter; HbA1C; glycated haemoglobin; tHcy; total homocyeteine; HDL; high density
Keywords: T2DM; Type 2 diabetes mellitus; STZ; Streptozotocin; NA; Nicotinamide; (i.p.); Intraperitoneal; IPGTT; Intraperitoneal glucose tolerance test; TC; Total cholesterol; TG; Triglyceride; HDL; High-density lipoprotein-cholesterol; LDL-C; Low-density lipoprote
Keywords: LFD; low-fat diet; BD; basal diet; HFD; high-fat diet; NDs; normal diets; ME; metabolizable energy; BW; body weight; ADFI; average daily feed intake; ADMEI; average daily metabolizable energy intake; GLU; glucose; TG; triglycerides; TC; total cholesterol;
Keywords: Fibroblast growth factor 19; Visceral fat accumulation; Glucose tolerance status; ANCOVA; analysis of covariance; ANOVA; One-way analysis of variance; BA; bile acid; BMI; body mass index; DBP; diastolic blood pressure; DM; diabetes mellitus; FFM; free fat
Keywords: IUGR; intrauterine growth retardation; PNE; prenatal nicotine exposure; TCH; total cholesterol; HDL-C; high-density lipoprotein-cholesterol; LDL-C; low-density lipoprotein-cholesterol; SR-B1; scavenger receptor class B type 1; ABCA1; ATP-binding cassette